Novel elucidation and treatment of pancreatic chronic graft-versus-host disease in mice

Shin Mukai, Yoko Ogawa, Fumihiko Urano, Yutaka Kawakami, Kazuo Tsubota

Research output: Contribution to journalArticle

Abstract

Chronic graft-versus-host disease (cGVHD) is a severe complication of allogeneic haematopoietic stem cell transplantation. There is a growing understanding of cGVHD, and several effective therapies for cGVHD have been reported. However, pancreatic cGVHD is a potentially untapped study field. Our thought-provoking study using a mouse model of cGVHD suggested that the pancreas could be impaired by cGVHD-induced inflammation and fibrosis and that endoplasmic reticulum (ER) stress was augmented in the pancreas affected by cGVHD. These findings urged us to treat pancreatic cGVHD through reduction of ER stress, and we used 4-phenylbutyric acid (PBA) as an ER stress reducer. A series of experiments has indicated that PBA can suppress cGVHD-elicited ER stress in the pancreas and accordingly alleviate pancreatic cGVHD. Furthermore, we focused on a correlation between epithelial to mesenchymal transition (EMT) and fibrosis in the cGVHD-affected pancreas, because EMT was conceivably implicated in various fibrosis-associated diseases. Our investigation has suggested that the expression of EMT markers was increased in the cGVHD-disordered pancreas and that it could be reduced by PBA. Taken together, we have provided a clue to elucidate the pathogenic process of pancreatic cGVHD and created a potentially effective treatment of this disease using the ER stress alleviator PBA.

Original languageEnglish
Article number181067
JournalRoyal Society Open Science
Volume5
Issue number10
DOIs
Publication statusPublished - 2018 Oct 1

Fingerprint

Graft vs Host Disease
Endoplasmic Reticulum Stress
Pancreas
Epithelial-Mesenchymal Transition
Therapeutics
Fibrosis
Hematopoietic Stem Cell Transplantation

Keywords

  • 4-phenylbutyric acid
  • Endoplasmic reticulum stress
  • Fibrosis
  • Inflammation
  • Pancreatic graft-versus-host disease

ASJC Scopus subject areas

  • General

Cite this

Novel elucidation and treatment of pancreatic chronic graft-versus-host disease in mice. / Mukai, Shin; Ogawa, Yoko; Urano, Fumihiko; Kawakami, Yutaka; Tsubota, Kazuo.

In: Royal Society Open Science, Vol. 5, No. 10, 181067, 01.10.2018.

Research output: Contribution to journalArticle

Mukai, Shin ; Ogawa, Yoko ; Urano, Fumihiko ; Kawakami, Yutaka ; Tsubota, Kazuo. / Novel elucidation and treatment of pancreatic chronic graft-versus-host disease in mice. In: Royal Society Open Science. 2018 ; Vol. 5, No. 10.
@article{bc2d33dddead44a48810e5b1ab3f3a1d,
title = "Novel elucidation and treatment of pancreatic chronic graft-versus-host disease in mice",
abstract = "Chronic graft-versus-host disease (cGVHD) is a severe complication of allogeneic haematopoietic stem cell transplantation. There is a growing understanding of cGVHD, and several effective therapies for cGVHD have been reported. However, pancreatic cGVHD is a potentially untapped study field. Our thought-provoking study using a mouse model of cGVHD suggested that the pancreas could be impaired by cGVHD-induced inflammation and fibrosis and that endoplasmic reticulum (ER) stress was augmented in the pancreas affected by cGVHD. These findings urged us to treat pancreatic cGVHD through reduction of ER stress, and we used 4-phenylbutyric acid (PBA) as an ER stress reducer. A series of experiments has indicated that PBA can suppress cGVHD-elicited ER stress in the pancreas and accordingly alleviate pancreatic cGVHD. Furthermore, we focused on a correlation between epithelial to mesenchymal transition (EMT) and fibrosis in the cGVHD-affected pancreas, because EMT was conceivably implicated in various fibrosis-associated diseases. Our investigation has suggested that the expression of EMT markers was increased in the cGVHD-disordered pancreas and that it could be reduced by PBA. Taken together, we have provided a clue to elucidate the pathogenic process of pancreatic cGVHD and created a potentially effective treatment of this disease using the ER stress alleviator PBA.",
keywords = "4-phenylbutyric acid, Endoplasmic reticulum stress, Fibrosis, Inflammation, Pancreatic graft-versus-host disease",
author = "Shin Mukai and Yoko Ogawa and Fumihiko Urano and Yutaka Kawakami and Kazuo Tsubota",
year = "2018",
month = "10",
day = "1",
doi = "10.1098/rsos.181067",
language = "English",
volume = "5",
journal = "Royal Society Open Science",
issn = "2054-5703",
publisher = "The Royal Society",
number = "10",

}

TY - JOUR

T1 - Novel elucidation and treatment of pancreatic chronic graft-versus-host disease in mice

AU - Mukai, Shin

AU - Ogawa, Yoko

AU - Urano, Fumihiko

AU - Kawakami, Yutaka

AU - Tsubota, Kazuo

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Chronic graft-versus-host disease (cGVHD) is a severe complication of allogeneic haematopoietic stem cell transplantation. There is a growing understanding of cGVHD, and several effective therapies for cGVHD have been reported. However, pancreatic cGVHD is a potentially untapped study field. Our thought-provoking study using a mouse model of cGVHD suggested that the pancreas could be impaired by cGVHD-induced inflammation and fibrosis and that endoplasmic reticulum (ER) stress was augmented in the pancreas affected by cGVHD. These findings urged us to treat pancreatic cGVHD through reduction of ER stress, and we used 4-phenylbutyric acid (PBA) as an ER stress reducer. A series of experiments has indicated that PBA can suppress cGVHD-elicited ER stress in the pancreas and accordingly alleviate pancreatic cGVHD. Furthermore, we focused on a correlation between epithelial to mesenchymal transition (EMT) and fibrosis in the cGVHD-affected pancreas, because EMT was conceivably implicated in various fibrosis-associated diseases. Our investigation has suggested that the expression of EMT markers was increased in the cGVHD-disordered pancreas and that it could be reduced by PBA. Taken together, we have provided a clue to elucidate the pathogenic process of pancreatic cGVHD and created a potentially effective treatment of this disease using the ER stress alleviator PBA.

AB - Chronic graft-versus-host disease (cGVHD) is a severe complication of allogeneic haematopoietic stem cell transplantation. There is a growing understanding of cGVHD, and several effective therapies for cGVHD have been reported. However, pancreatic cGVHD is a potentially untapped study field. Our thought-provoking study using a mouse model of cGVHD suggested that the pancreas could be impaired by cGVHD-induced inflammation and fibrosis and that endoplasmic reticulum (ER) stress was augmented in the pancreas affected by cGVHD. These findings urged us to treat pancreatic cGVHD through reduction of ER stress, and we used 4-phenylbutyric acid (PBA) as an ER stress reducer. A series of experiments has indicated that PBA can suppress cGVHD-elicited ER stress in the pancreas and accordingly alleviate pancreatic cGVHD. Furthermore, we focused on a correlation between epithelial to mesenchymal transition (EMT) and fibrosis in the cGVHD-affected pancreas, because EMT was conceivably implicated in various fibrosis-associated diseases. Our investigation has suggested that the expression of EMT markers was increased in the cGVHD-disordered pancreas and that it could be reduced by PBA. Taken together, we have provided a clue to elucidate the pathogenic process of pancreatic cGVHD and created a potentially effective treatment of this disease using the ER stress alleviator PBA.

KW - 4-phenylbutyric acid

KW - Endoplasmic reticulum stress

KW - Fibrosis

KW - Inflammation

KW - Pancreatic graft-versus-host disease

UR - http://www.scopus.com/inward/record.url?scp=85056774703&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056774703&partnerID=8YFLogxK

U2 - 10.1098/rsos.181067

DO - 10.1098/rsos.181067

M3 - Article

AN - SCOPUS:85056774703

VL - 5

JO - Royal Society Open Science

JF - Royal Society Open Science

SN - 2054-5703

IS - 10

M1 - 181067

ER -